Familial colorectal cancer type X: Clinical, pathological and molecular characterization;Carcinoma colorectal familiar de tipo X: Caracterização clínica, patológica e molecular

Acta Medica Portuguesa

Volumn 22, Issue 3, 2009, Pages 207-214

  Ferreira, Sara ^a   Lage, Pedro ^a   Sousa, Rita ^a   Claro, Isabel ^a   Francisco, Inês ^a   Filipe, Bruno ^a   Suspiro, Alexandra ^a   Chaves, Paula ^a   Rodrigues, Paula ^a   Albuquerque, Cristina ^a   Nobre Leitao C ^a  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

APC; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; PROTEIN P53; SMAD4 PROTEIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DELETED IN COLON CANCER GENE; DESCENDING COLON; DNA REPAIR; FAMILIAL CANCER; FAMILIAL COLORECTAL CANCER TYPE X; GENE; GENE MUTATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; LYMPHOCYTE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MUCUS GLAND; MUTATIONAL ANALYSIS; RECTUM; ADULT; AGED; COLORECTAL TUMOR; FEMALE; GENETICS; MALE; MIDDLE AGED;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 70449725279     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. LYNCH HT, DE LA CHAPELLE A: Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999;36:801-818
2. WATSON P, LYNCH HT: Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993;71:677-685
3. VASEN HF, MECKLIN JP, KHAN PM, LYNCH HT: The International Collaborative Group on Herediatry Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5
4. VASEN HF, WATSON P, MECKLIN JP, LYNCH HT: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterol 1999;116:1453-6
5. LYNCH HT, DE LA CHAPELLE A: Hereditary colorectal cancer. N Engl J Med 2003;348:919-932
6. LLOR X, PONS E, XICOLA R et al: Differential features of colorectal cancers fulfilling Amsterdam Criteria without involvement of the mutator pathway. Clin Cancer Res 2005;11:7304-10
7. CAHILL DP, LENGAUER C, YU J et al: Mutations of mitotic checkpoint genes in human cancers. Nature 1998;392:300-3
8. LAMBERTI C, KRUSE R, RUELFS C et al: Microsatellite instability: a useful diagnostic tool to select patients at high risk for hereditary non-polyposis colorectal cancer - a study in different groups of patients with colorectal cancer. Gut 1999;44:839-843
9. SAMOWITZ WS, CURTIN K, LIN HH et al: The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterol 2001;121:830-8
10. LINDOR N, RABE K, PETERSEN G et al: Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency (Familial Colorectal Cancer Type X). JAMA 2005;293:1979-85
11. LYNCH HT, BOLAND CR, GONG G et al: Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet 2006;14:390-402
12. JASS JR, COTTIER DS, JEEVARATNAM P et al: Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer. Lancet 1995;346:1200-1
13. WIGGERS T, ARENDS JW, SCHUTTE B, VOLOVICS L, BOSMAN FT: A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer 1986;61:386-395
14. MORSON BC, SOTIN LH: Types histologiques dês tumeurs intestinales. Classification histologique internationale dês tumeurs. No 15, 1976
15. BOLAND CR, THIBODEAU SN, HAMILTON SR et al: A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57
16. JASS J: Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J Gastroenterol 2006; 12:4943-50
17. AALTONEN LA, PELTOMAKI P, LEACH FS et al: Clues to the pathogenesis of familial colorectal câncer. Science 1993;260:812-6
18. LYNCH HT, LYNCH J: Lynch syndrome. genetics, natural history, genetic counselling and prevention. J Clin Oncol 2000;18:19S-31S
19. FERREIRA S, CLARO I, FRANCISCO I et al: A pesquisa de grandes delecções nos genes MLH1 e MSH2 aumenta a eficácia do diagnóstico genético na Síndroma de Lynch. GE - Jornal Português de Gastrenterologia 2005;12(Suppl):19 (publicado sob a forma de abstract)
20. VALLE L, PEREA J, CARBONELL P et al: Clinicopathologic and pedigree differences in Amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status. J Clin Oncol 2007;25:781-6
21. BUTTIN BM, POWELL MA, MUTCH DG et al: Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am J Hum Genet 2004; 74:1262-9
22. HAMPEL, FRANKEL WL, MARTIN E et al: Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005;352:1851-60
23. MUELLER-KOCH Y, VOGELSANG H, KOPP R et al: Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut 2005;54:1733-40
24. JASS JR, BIDEN KG, CUMMINGS MC et al: Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol 1999;52:455-460
25. ROWAN AJ, LAMLUM H, ILYAS M et al: APC mutations in sporadic colorectal tumors: a mutational «hotspot» and interdependence of the «two hits». PNAS 2000;97:3352-7
26. MIYAKI M, IIJIMA T, KIMURA J et al: Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res 1999;59:4506-9
27. HUANG J, ZHENG S, JIN S-H, ZHANG S-Z: Somatic mutations of APC gene in carcinomas from hereditary non-polyposis colorectal cancer patients. World J Gastroenterol 2004;10:834-6
28. LAMLUM H, ILYAS M, ROWAN A et al: The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's «two-hit» hypothesis. Nat Med 1999;5:1071-5
29. ALBUQUERQUE C, BREUKEL C, VAN DER LUIJT R et al The «just- right» signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum Mol Genet 2002;11:1549-60